查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1793891

全球血栓治療市場

Thrombus Treatment
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 296 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球血栓治療市場規模將達 557 億美元

全球血栓治療市場規模預計在2024年為408億美元，到2030年將達到557億美元，在分析期間（2024-2030年）的複合年成長率為5.3%。心房血栓是本報告分析的細分市場之一，預計其複合年成長率為6.8%，到分析期結束時將達到280億美元。右心房血栓細分市場在分析期間的複合年成長率估計為3.6%。

美國市場規模估計為 111 億美元，中國市場預計複合年成長率為 8.7%

美國血栓治療市場規模預計2024年達到111億美元。作為世界第二大經濟體，中國預計2030年市場規模將達到113億美元，在2024-2030年的分析期間內，複合年成長率為8.7%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為2.5%和5.3%。在歐洲，預計德國市場的複合年成長率為3.5%。

全球血栓栓塞治療市場—主要趨勢與促進因素摘要

血栓管理是否會從緊急應變演變為有針對性的干涉？

血栓治療曾經是被動的，專注於抗凝血和機械血栓切除等緊急干預措施，但目前正在經歷重大變革時期。隨著臨床認知的提高和治療流程的演變，血栓管理正朝著更早、更精準、更特異性患者的策略轉變。血栓－在血管內形成的血塊－可導致危及生命的疾病，例如深層靜脈栓塞症(DVT)、肺動脈栓塞(PE)、心肌梗塞和缺血性中風。由於人口老化和久坐不動的生活方式，全球血栓性栓塞症負擔日益加重，醫療保健系統持續需要擴充性的先進治療方法。

現代血栓管理有三大支柱：藥物治療、導管介入治療和預防性護理。雖然抗凝血劑仍然是大多數治療方案的基石，但導管溶栓、抽吸血栓切除術和新型機械裝置在高風險或難治性病例中正變得越來越普遍。此外，意識和檢測能力的提高使得早期診斷血栓成為可能，有時甚至在臨床症狀出現之前就能診斷出來，從而能夠對高風險患者群體進行預防性治療。這種模式轉移正在重新定義血栓治療，從危機管理轉向持續降低風險和個人化治療。

藥物創新和血管內裝置如何重新定義照護標準？

在藥理學方面，Apixaban、利伐沙班和依度沙班等直介面服抗凝血劑 (DOAC) 的開發徹底改變了血栓栓塞治療的格局，與Warfarin相比，它們具有可預測的藥物動力學、更少的監測要求和更低的出血風險。這些藥物在醫院和門診中擴大用於預防心房顫動患者的深部靜脈栓塞 (DVT)、肺栓塞 (PE) 和中風。此外，目前正在研究下一代更具選擇性的抗血栓和逆轉劑，以提高外科和創傷患者的安全性。

同時，機械血栓切除術和導管介導血栓溶解術 (CDT) 的興起正在顯著改變急性血栓事件的治療通訊協定。這些微創手術可以進行標靶血栓切除和局部藥物輸送，最大限度地減少全身暴露和出血併發症。抽吸導管、自動擴張型支架取栓器和超音波輔助血栓溶解系統等設備正在不斷改進，以提高其在腦、肺、冠狀動脈和周邊血管床中的療效。結合機械和藥物治療的混合療法的出現，加快了血栓溶解速度，改善了功能預後，特別是對於需要即時恢復灌注的中風和腦血管性心臟疾病患者。

早期檢測、風險分析和預防性治療能否擴大市場？

血栓管理的關鍵趨勢是強調預防和早期風險識別。穿戴式科技、人工智慧輔助影像和預測風險評分工具正被用於檢測高風險族群（例如術後患者、孕婦以及心房顫動或癌症患者）的血栓形成傾向。這些工具使臨床醫生能夠更早啟動預防性治療，並降低住院率。在外科手術中，術中血栓監測和手術全期抗凝血方案正在標準化，以最大限度地減少術後併發症。

長期血栓管理的應用範圍也不斷擴大，尤其對於復發性血栓和慢性血栓栓塞性肺動脈高壓 (CTEPH) 患者而言。門診抗凝血診所、遠端 INR 監測和居家照護模式正在使終身血栓管理更加便利和永續。此外，越來越重視基於生物標記、遺傳易感性和合併症的患者分層，這使得制定更精細、風險調整後的治療方案成為可能。這種精準方法正在血栓管理領域創造新的細分市場，包括個人化給藥方案、利基診斷和個人化設備的部署。

哪些因素推動了抗血栓治療市場的成長？

抗血栓治療市場的成長受到與治療創新、介入技術和臨床工作流程整合相關的若干融合因素的推動。首先，DOAC因其安全性、有效性和易用性而被廣泛採用，這正在重塑住院和門診的抗血栓治療。其次，導管機械血栓切除術在中風、肺栓塞和周邊血栓形成中的廣泛應用，正在為微創治療樹立新的標準。

第三，診斷影像（例如 CT血管造影術、超音波超音波）的改進和基於人工智慧的風險評估工具的使用使得診斷更快、治療更準確。第四，人口老化、肥胖率上升和心房顫動盛行率上升等人口因素正在擴大高風險患者群體，需要更積極的預防和治療性介入。第五，持續的技術創新，包括微型儀器、軟性導管技術和整合影像引導系統，正在使血管內手術更安全、更有效。最後，向基於價值的護理和捆綁報銷模式的轉變正在鼓勵醫院採用可減少併發症、再入院率和整體治療成本的血栓管理通訊協定。這些趨勢的融合使血栓管理成為血管和循環系統護理中最具創新性和臨床活力的領域之一。

部分

類型（心房血栓型、右心房血栓型、左心房血栓型、靜脈血栓型）；治療（藥物治療、抗血小板治療、抗凝血治療、血栓溶解治療、手術治療、其他治療）

受訪公司範例

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • Bayer AG
  • Boehringer Ingelheim
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Cardinal Health, Inc.
  • Cook Medical
  • Daiichi Sankyo Company, Limited
  • Edwards Lifesciences Corporation
  • Genentech（F. Hoffmann-La Roche）
  • Inari Medical, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer Inc.
  • Stryker Corporation

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP38206

Global Thrombus Treatment Market to Reach US$55.7 Billion by 2030

The global market for Thrombus Treatment estimated at US$40.8 Billion in the year 2024, is expected to reach US$55.7 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Atrial Thrombus Type, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$28.0 Billion by the end of the analysis period. Growth in the Right Atrial Thrombus Type segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.1 Billion While China is Forecast to Grow at 8.7% CAGR

The Thrombus Treatment market in the U.S. is estimated at US$11.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Thrombus Treatment Market - Key Trends & Drivers Summarized

Is Thrombus Management Evolving From Emergency Response to Targeted Intervention?

Thrombus treatment, once largely reactive and centered around emergency interventions like anticoagulation and mechanical thrombectomy, is now undergoing a significant transformation. As clinical understanding deepens and treatment algorithms evolve, thrombus management is moving toward earlier, more precise, and patient-specific strategies. A thrombus-a blood clot formed within a vessel-can lead to life-threatening conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), myocardial infarction, and ischemic stroke. The global burden of thromboembolic disorders, amplified by aging populations and sedentary lifestyles, continues to push healthcare systems toward scalable, advanced treatment approaches.

Modern thrombus treatment is characterized by three pillars: pharmacological therapy, catheter-based intervention, and preventive care. While anticoagulants remain the foundation for most treatment plans, catheter-directed thrombolysis, aspiration thrombectomy, and novel mechanical devices are becoming common in high-risk or refractory cases. Additionally, growing awareness and detection capabilities are enabling earlier diagnosis of thrombi, sometimes even before clinical symptoms manifest-leading to preemptive therapy in high-risk patient groups. This paradigm shift is redefining thrombus care from crisis management to continuous risk mitigation and personalized therapy.

How Are Drug Innovations and Endovascular Devices Redefining Care Standards?

On the pharmacological front, the development of direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, and edoxaban has changed the landscape of thrombus treatment by offering predictable pharmacokinetics, reduced monitoring needs, and lower bleeding risk compared to warfarin. These agents are increasingly used in both hospital and outpatient settings for DVT, PE, and stroke prevention in atrial fibrillation. Research is also advancing into next-generation antithrombotics with higher selectivity and reversal agents that enhance safety profiles for surgical or trauma patients.

Meanwhile, the rise of mechanical thrombectomy and catheter-directed thrombolysis (CDT) is transforming treatment protocols for acute thrombotic events. These minimally invasive procedures allow for targeted clot removal or localized drug delivery, minimizing systemic exposure and bleeding complications. Devices such as aspiration catheters, self-expanding stent retrievers, and ultrasonic-assisted thrombolysis systems are being fine-tuned to enhance efficacy across vascular beds-cerebral, pulmonary, coronary, and peripheral. The ability to combine mechanical and pharmacological therapies in hybrid procedures is yielding faster clot resolution and better functional outcomes, particularly in stroke and PE patients who require immediate restoration of perfusion.

Can Early Detection, Risk Profiling, and Preventive Therapies Expand Market Reach?

A critical trend in thrombus treatment is the emphasis on prevention and early risk identification. Wearable technologies, AI-assisted imaging, and predictive risk scoring tools are being used to detect thrombotic tendencies in high-risk populations-such as post-operative patients, pregnant women, and individuals with atrial fibrillation or cancer. These tools enable clinicians to initiate prophylactic therapy earlier and reduce hospitalization rates. In surgical settings, intraoperative thrombus monitoring and perioperative anticoagulation protocols are being standardized to minimize post-procedure complications.

Long-term thrombus management is also expanding, especially for patients with recurrent events or chronic thromboembolic pulmonary hypertension (CTEPH). Outpatient anticoagulation clinics, remote INR monitoring, and home-based care models are making lifelong thrombus management more accessible and sustainable. Moreover, increasing focus on patient stratification-based on biomarkers, genetic predisposition, and comorbidities-is enabling more refined, risk-adjusted therapy plans. This precision approach is creating new submarkets within thrombus care, including personalized dosage regimens, niche diagnostics, and tailored device deployment.

What Factors Are Accelerating Growth in the Thrombus Treatment Market?

The growth in the thrombus treatment market is driven by multiple converging factors related to therapeutic innovation, interventional techniques, and clinical workflow integration. First, the expanding adoption of DOACs-due to their safety, efficacy, and ease of use-is reshaping both inpatient and outpatient thrombus care. Second, the increasing use of catheter-based and mechanical thrombectomy systems in stroke, PE, and peripheral thrombi is establishing new standards in minimally invasive treatment.

Third, improvements in diagnostic imaging (e.g., CT angiography, duplex ultrasound) and the use of AI-assisted risk assessment tools are enabling faster diagnosis and more accurate therapy initiation. Fourth, demographic factors such as aging populations, rising obesity rates, and the increasing prevalence of atrial fibrillation are swelling the at-risk patient pool, prompting more aggressive prophylactic and therapeutic interventions. Fifth, ongoing innovations in device miniaturization, flexible catheter technologies, and integrated imaging-guided systems are making endovascular approaches safer and more effective. Lastly, the shift toward value-based care and bundled reimbursement models is encouraging hospitals to adopt thrombus management protocols that reduce complications, readmissions, and overall treatment costs. These dynamics are converging to make thrombus treatment one of the most innovation-driven and clinically dynamic segments in vascular and cardiovascular care.

SCOPE OF STUDY:

The report analyzes the Thrombus Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type, Venous Thrombus Type); Treatment (Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment, Surgery Treatment, Other Treatments)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • Bayer AG
  • Boehringer Ingelheim
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Cardinal Health, Inc.
  • Cook Medical
  • Daiichi Sankyo Company, Limited
  • Edwards Lifesciences Corporation
  • Genentech (F. Hoffmann-La Roche)
  • Inari Medical, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer Inc.
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Thrombus Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular and Stroke-Related Events Fuels Demand for Thrombus Therapies
    • Adoption of Catheter-Directed Thrombolysis Supports Minimally Invasive Treatment Growth
    • Increased Use of Mechanical Thrombectomy Devices Enhances Acute Stroke Intervention Success
    • Advancements in Clot-Dissolving Agents Improve Efficacy in DVT and PE Management
    • Expansion of Interventional Cardiology Capabilities Drives Procedural Volumes for Clot Removal
    • Rising Awareness of Venous Thromboembolism Prevention in Post-Surgical Settings Supports Prophylactic Drug Use
    • Integration of Imaging Technologies With Treatment Planning Enhances Patient Selection Accuracy
    • Development of Next-Gen Devices With Reduced Embolization Risk Supports Adoption in High-Risk Patients
    • Growth in Stroke Centers and Specialized Units Enhances Access to Timely Thrombus Treatment
    • Demand for Rapid-Recovery Solutions Drives Hospital Preference for Mechanical Devices Over Systemic Agents
    • Increased Investment in Stroke and Vascular Health Campaigns Supports Early Presentation and Diagnosis
    • Growing Pipeline of Anti-Thrombotic Agents Expands Therapeutic Options in Refractory Cases
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Thrombus Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Thrombus Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Atrial Thrombus Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Right Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Right Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Right Atrial Thrombus Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Left Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Left Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Left Atrial Thrombus Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Venous Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Venous Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Venous Thrombus Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Medical Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Medical Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Medical Therapy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Antiplatelets Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Antiplatelets Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Antiplatelets Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Anticoagulants Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Anticoagulants Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Anticoagulants Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Thrombolytics Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Thrombolytics Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Thrombolytics Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Surgery Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Surgery Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Surgery Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • JAPAN
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • CHINA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • EUROPE
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Thrombus Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • FRANCE
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: France 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: France 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • GERMANY
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Thrombus Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • INDIA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: India 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: India 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Thrombus Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Thrombus Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • AFRICA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030

IV. COMPETITION